ArticleEpigenetics2011

Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.

Kun-Tu Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.